Table 1 Characteristics of patients used in this study.
Cohorts (Number of images) | Treatment type | Used for | Image | Cancer types** (Number of patients) | Median Voxel size (in x/y, mm)┼ | Median Voxel size (in z, mm)┼ |
|---|---|---|---|---|---|---|
\({{\text{C}}}_{{\text{RTTrain}}}\)(N = 160) | Radiotherapy | Training | Contrast | HCC = 30 CC = 49 CRM = 12 mixed = 4 | 0.98 (0.66–1.17) | 2.5 (0.63–5.0) |
\({{\text{C}}}_{{\text{RTVal}}}\)(N = 40) | Radiotherapy | Validation | Contrast | HCC = 16 CC = 18 CRM = 2 | 0.98 (0.7–1.07) | 2.5 (2.5–5.0) |
\({{\text{C}}}_{{\text{LS}}}\)(N = 33) | Liver surgery evaluation | Test | Contrast | HCC = 2 CC = 5 CRM = 22 | 0.86 (0.51–0.98) | 2.5 (2.5–5.0) |
\({{\text{C}}}_{{\text{PVE}}}\)(N = 20) | Portal vein embolization | Test | Contrast | HCC = 0 CC = 3 CRM = 17 | 0.80 (0.70–0.98) | 2.5 (1.0–2.5) |
\({{\text{C}}}_{{\text{CH}}}\)(N = 25) | Liver segmentation challenge | Test | Contrast | NA | 0.71 (0.60–0.96) | 2 (1.0–5.0) |
\({{\text{C}}}_{{\text{CNC}}}\)(N = 20) | Pre-contrast of \({{\text{C}}}_{{\text{RT}}}\) | Perturbation study | Non-contrast | HCC = 6 CC = 10 CRM = 3 mixed = 1 | 0.98 (0.98–1.17) | 2.5 (all*) |
